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ABSTRACT
Cancer predisposition syndromes (CPS), caused by germline pathogenic
variants in tumor suppressor genes and oncogenes, are genetic conditions that
put an individual at increased risk to develop cancer. It is estimated that 10-15%
of children with cancer have an underlying CPS. Although genetic testing for
these conditions has become routine in the adult setting, incorporation of
germline genomic technologies into pediatric cancer care has not occurred as
rapidly. The purpose of this study is to assess desire for genetic counseling and
testing services among parents of children with cancer to provide parental
insight in the incorporation of genomic technologies in this health care setting.
Forty-two parents of individuals diagnosed with cancer less than 18 years of age
completed either a paper (n=8) or online survey (n=34) regarding their child's
cancer history, personal perspectives on genetic counseling, and
family/demographic information. Interest in genetic testing for CPS was variable,
with 50% of respondents indicating they would be interested in pursuing genetic
testing for their affected child while one-third of respondents indicated that they
were unsure if they would pursue genetic testing. The factors most commonly
cited as impacting interest in genetic counseling/testing include the potential for
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modification of medical care for family members and for the child’s treatment
based on results. A subset of parents expressed that concerns for genetic
discrimination and potential negative impact on mental health would negatively
influence their interest in genetic testing for CPS. Genetic counselors have an
ideal skillset to help families weigh the benefits and drawbacks of genetic testing
for CPS in childhood in order to facilitate decision-making among this
population as the availability and clinical utility of genomic testing increases.
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CHAPTER 1
LITERATURE REVIEW
1.1 Overview of pediatric cancer predisposition syndromes
Cancer predisposition syndromes (CPS), caused by germline pathogenic
variants in tumor suppressor genes and oncogenes, are conditions that put an
individual at increased risk to develop a specific set of cancers throughout their
lifetime. CPS, also called hereditary cancer syndromes, have been recognized
since Alfred Knudson Jr.’s 1971 publication on hereditary retinoblastoma and the
two-hit hypothesis but have become more widely acknowledged by the medical
community and the general public due in part to articles about the BRCA1 and
BRCA2 genes in mainstream media as well as the availability of clinical genetic
testing (Jolie, 2013; Knudson, 1971). Historically, scientific knowledge about
cancer predisposition in childhood (<18 years old) was limited to the context of
complex genetic conditions such as Beckwith-Wiedemann syndrome (BWS) and
Down syndrome, which increase a child’s risk for embryonal tumors and
hematologic malignancies, respectively (Clericuzio, 1999). With the advent of
next generation sequencing (NGS) and incorporation of genetic testing for adult
hereditary cancer syndromes into routine clinical care, cancer genetics research
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has expanded to include the use of genomic testing for tumor and germline
analysis in pediatric cancer populations. Through these efforts, further links
between germline variants and increased risk of childhood cancer are becoming
more well defined.
It is estimated that approximately 10-15% of childhood cancers can be
attributed to an underlying germline mutation. A study by Zhang et al. (2015)
found an overall prevalence of germline mutations in 8.5% of patients with all
major subtypes of childhood cancer under 20 years of age enrolled in the
Pediatric Cancer Genome Project (PCGP). The proportion of germline mutations
in their cohort was significantly greater than the prevalence of cancer
predisposition syndromes in the 1000 genomes project, which was used as a
control group (Zhang et al., 2015).
In addition to research on germline mutations associated with cancer,
multiple groups have performed genomic analysis of tumor samples by using
whole exome sequencing (WES), whole transcriptome/RNA sequencing (WTS),
and copy number analysis via microarray to identify clinically actionable
findings in the treatment of a wide variety of childhood tumor types. Genomic
analysis of tumors in these studies resulted in clinically actionable findings for
between 38% and 51% of patients. For the purposes of these research projects,
clinically actionable findings most often referred to those that would directly
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impact medical management such as using a targeted therapy. In these studies,
WES was also performed on germline tissues, to assess prevalence of cancer
predisposition syndromes. Prevalence of CPS varied from 10-14%, with the
highest prevalence identified in a cohort of children that were considered
clinically high-risk (Chang et al., 2016; Mody et al., 2015; Oberg et al., 2016;
Parsons et al., 2016). The inclusion criteria for each study were different, which
may have contributed to the prevalence ranges, and the prevalence of germline
mutations in cancer predisposition genes varied based on cancer type.
Certain cancer types have strong associations with hereditary cancer
predisposition syndromes, such as adrenocortical carcinoma and Li-Fraumeni
syndrome; whereas many childhood hematologic malignancies, such as acute
promyelocytic leukemia, are less likely to be associated with a specific cancer
syndrome. Aside from cancer type there are a few other clues that healthcare
providers can use to identify individuals with an inherited cancer predisposition
syndrome, thus facilitating appropriate clinical management. Genetics
professionals such as genetic counselors and medical geneticists combine
information such as family history and clinical features with information about
an individual’s tumor type, pattern and age of onset to determine the likelihood
of a cancer predisposition syndrome (Knapke, Zelley, Nichols, Kohlmann, &
Schiffman, 2012; Schiffman, 2012; Schiffman et al., 2013). Despite the sizable
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prevalence of CPS among patients with childhood cancers, in 2016 there were
only 16 pediatric cancer genetic counselors in the United States of America
according to the Professional Status Survey of the National Society of Genetic
Counselors (National Society of Genetic Counselors, n.d.). This means that many
medical centers that provide childhood cancer care do not yet have genetics
professionals integrated into their pediatric oncology departments.
Due to these recent studies and the subsequent increasing awareness of
childhood hereditary cancer syndromes, organizations including the Society for
Pediatric Oncology and Hematology and members of the National Society of
Genetic Counselors have published review articles for their members. These
reviews provide general overviews of the types of cancer seen in childhood and
their associations with known cancer predisposition syndromes.
Recommendations on when to consider a childhood cancer predisposition
syndrome, colloquially referred to as “red-flags”, are also mentioned in the
reviews. Although these do not encompass every syndrome with childhood
cancer risk, these articles are intended to provide succinct information about
common cancer predisposition syndromes as well as tips for how to identify
individuals who may benefit from genetics consultation (Ripperger et al., 2017;
Saletta, Dalla Pozza, & Byrne, 2015; Scollon, Anglin, Thomas, Turner, &
Schneider, 2017).
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1.2 Genetic counseling referral criteria
Although these review articles provide a general introduction to
childhood cancer predisposition and “red-flags” that should prompt
consideration of a genetics referral, specific referral criteria are out of the scope of
these reviews. In one of the first studies of pediatric cancer genetic risk
assessment, Knapke et al (2012) reviewed charts of individuals in a pediatric
cancer survivorship clinic and determined that 29% of individuals in their cohort
would be eligible for a genetics consultation, with pediatric cancer or family
history of cancer as the primary referral indication (Knapke, Nagarajan, Correll,
Kent, & Burns, 2012). In response to the Knapke study, several institutions have
developed clinical screening tools to identify individuals at risk for childhood
cancer predisposition syndromes that would justify referral to genetic counseling
and/or clinical genetics. These clinical screening tools incorporate tumor type,
clinical features, and family history to identify those individuals that would be
most appropriate for genetics referral.
There are three main referral tools that range in complexity and are
variable in their approach to eliciting information. The simplest of the three is a
one-page document published by Jongmans et al. in 2016, which provides
general criteria that can be applied to any child with cancer (Jongmans et al.,
2016). The second referral tool, called the Tumor Predisposition Syndromes in
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Childhood Cancer Patients (TuPS) was first developed in 2013 and revised in
2017 by the Department of Pediatric Oncology of Emma Children's Hospital. In
both iterations of the TuPS, clinicians are prompted to include more detailed
information about patient and family history targeted towards specific CPS, yet
the tool still remains applicable to all pediatric cancer types (Hopman et al., 2013;
Postema, Hopman, de Borgie, et al., 2017). Lastly, the McGill Interactive Pediatric
OncoGenetic Guidelines (MIPOGG) is the most specialized of the referral tools.
The authors outlined a set of universal criteria, similar to those in the tool by
Jongmans et al., but also provide information on the development of tumorspecific algorithms that ultimately will be reviewed by panels of experts and
incorporated into a mobile application (Goudie et al., 2017). Although these
instruments vary in their approach, the three primary categories of tumor type,
clinical features, and family history are reflected in each referral tool.
1.2.1 Tumor types associated with automatic referral
Perhaps the most straightforward referral criteria captured by these
clinical screening tools are malignancies that automatically warrant referral to a
genetics team even in the absence of congenital anomalies or significant family
history. The referral tools include several pediatric tumor types that
automatically warrant genetics referral, but the number of tumor types included
varies between 20 and 34 depending on the tool. These tumor types are selected
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for inclusion in the referral tool based on the incidence of cancer predisposition
syndromes among individuals diagnosed with a specific tumor type. Incidence
to appropriately warrant automatic referral is often defined as greater than 510%.
Although not a formal referral tool, Plon and Nathanson (2005) discuss
twelve pediatric tumor types in which there is at least a 10% incidence of cancer
predisposition. Among these tumor types is retinoblastoma, with the chance of a
germline pathogenic variant in the RB1 gene up to 15% in individuals with
unilateral disease and approaches 100% in individuals with bilateral disease.
Other tumor types in their list include adrenocortical carcinoma (ACC), 50-80%
of which are due to an inherited TP53 mutation resulting in a diagnosis of LiFraumeni syndrome (LFS), and a host of cancers associated with
neurofibromatosis type 1 (NF1) including juvenile myelomonocytic leukemia
(JMML), optic pathway tumors, and malignant peripheral nerve sheath tumors
(Plon & Nathanson, 2005). Age of tumor diagnosis is also incorporated into some
of the tumor type criteria with the most common example being any carcinoma
diagnosed in childhood (Jongmans et al., 2016; Postema, Hopman, Aalfs, et al.,
2017). The presence of multiple malignancies is also addressed in the referral
tools, although their focus is divergent. In the Jongmans tool, the authors include
comments regarding secondary malignancies that can be attributed to treatment
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modality. The MIPOGG by Goudie et al., however, put more emphasis on
bilateral and multifocal tumors (Goudie et al., 2017).
1.2.2 Clinical and family history related to genetics referral
The incorporation of clinical features in the referral tools can be more
challenging due to demanding clinic schedules of pediatric oncologists, and the
fact that many pediatric cancer predisposition syndromes are not associated with
congenital anomalies or dysmorphic features. A systematic approach to identify
children with cancer who may have a cancer predisposition syndrome based on
clinical features was published in 1999 by Carol Clericuzio. In the article, she
identifies 11 categories of major and minor malformations that can be evaluated
on physical exam and may help providers recognize the presence of a childhood
tumor predisposition syndrome (Clericuzio, 1999). The abnormalities described
by Clericuzio include differences in growth, various dermatologic findings, and
abnormalities of the gastrointestinal and genitourinary tracts among others, all of
which are associated with syndromic forms of cancer predisposition. The tool
published by Jongmans et al. provides general guidelines for relevant clinical
features like the categories of malformations described by Clericuzio. These
include congenital anomalies, growth and skin abnormalities, hematological
conditions, and immune deficiency (Jongmans et al., 2016). The TuPS screening
instrument incorporates specific examples of clinical features which may be
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indicative of a cancer predisposition syndrome. Each body system included on
the tool has between one and seven distinct features to guide a targeted physical
examination (Hopman et al., 2013; Postema, Hopman, de Borgie, et al., 2017). In
the MIPOGG, Goudie et al. discuss the associations of specific tumor types and
clinical features that together can be indicative of a cancer predisposition
syndrome. Since the information gained from this approach is much more
detailed, it is likely that the integration of clinical information into the tool
provides a more comprehensive and targeted assessment of the utility of genetics
referral for a given patient. However, with increased detail comes added
complexity; this can be time consuming in already busy practices (Goudie et al.,
2017).
All the screening instruments incorporate family history information;
however, some are more comprehensive than others. In the simplest referral tool
published by Jongmans et al., the family history section addresses general
patterns, such as “a first degree relative (parent or sibling) with cancer < 45 years
of age” and consanguinity (Jongmans et al., 2016). The universal criteria of the
MIPOGG are comparable to the Jongmans criteria in level of detail, but
incorporate different factors such as family member(s) with cancer in the same
organ regardless of age (Goudie et al., 2017). The TuPS tool, however, provides
space to include more detailed family history information. The original TuPS
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screening instrument included in the 2013 publication by Hopman et al. has
space to indicate both cancer and morphological abnormalities in the family. The
revision in 2017 expanded this section by asking users to indicate ethnic
background and prompting about non-oncologic features of the family history
including intellectual and learning disabilities (Hopman et al., 2013; Postema,
Hopman, de Borgie, et al., 2017). While the information captured by the TuPS
instrument is more comprehensive, the additional time required to complete it
may not be practical in a clinical setting.
1.3 Genetic counseling utility
From a clinical perspective, identification of a pediatric cancer
predisposition syndrome can be critical for a child’s clinical management. Like
many adult cancer predisposition syndromes, a clinical or molecular diagnosis of
a cancer predisposition syndrome can influence cancer screening initiation or
frequency to either prevent or detect cancer at an earlier and more treatable
stage. Cancer screening and management guidelines for genetic syndromes have
been proposed in the literature as early as the 1990s, and often were embedded in
articles discussing cancer predisposition syndromes and genetic testing
considerations for these syndromes (Clericuzio, 1999; Strahm & Malkin, 2006;
Teplick, Kowalski, Biegel, & Nichols, 2011). In the summer of 2017, however,
members of the Pediatric Cancer Working Group established by the American
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Association of Cancer Research (AACR) collaborated to publish several
syndrome-specific management guidelines in the Clinical Cancer Research
Pediatric Oncology Series. Screening guidelines proposed by the AACR for each
syndrome meet a list of criteria, including the existence of effective screening
modalities and a 5% or greater risk of developing cancer by the age of 20. These
AACR management guidelines were published in an effort to promote
consistency of care among pediatric oncology centers internationally (Brodeur,
Nichols, Plon, Schiffman, & Malkin, 2017).
Although there are several publications regarding appropriate clinical
indications for genetics referral and management guidelines for individuals
diagnosed with a pediatric tumor predisposition syndrome, recent research of
physicians in pediatric oncology has demonstrated a majority of providers lack
of comfort with the genetic testing process (Johnson et al., 2017). This study
identified a general lack of confidence in ordering, interpreting and discussing
results of somatic and germline clinical genomic and exome sequencing (CGES),
with 35% of providers expressing confidence with somatic results and 27%
expressing confidence with germline results. Regardless of provider confidence,
however, 93% of respondents stated a preference to include genetic counselors in
the process of germline results disclosure. The authors concluded that even
among specialized pediatric hematology and oncology providers at a National
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Comprehensive Cancer Network (NCCN) facility there is a need for additional
education and training about genomic testing and further argue in support of
incorporating genetic counselors into the subspecialty of pediatric oncology.
While providers indicate a preference for incorporation of genetic
counseling into pediatric cancer care, parent interest in genetic counseling among
this population remains unknown. Research of this type, however, has been done
in the adult population, which can provide a framework through which to
address this topic in the pediatric cancer population. In a systematic review,
Willis et al (2016) identified sociodemographic, psychosocial, and clinical factors
implicated in the utilization of genetic counseling services for adult hereditary
cancer. Age, sex, ethnicity, socioeconomic status, and marital status are among
the sociodemographic factors cited in their research. Psychosocial factors
impacting uptake of genetic counseling in the adult population include
knowledge of genetic counseling, perceived risk of cancer or a mutation,
perceived utility, and general distress. Referral characteristics such as timing
have also been studied in relation to genetic counseling interest and uptake.
Studies in adult populations have demonstrated that longer length of time
between treatment and referral, as well as poor referral timing in relation to
treatment is associated with decreased uptake of genetic counseling services.
Willis et al. provide a review of these findings, as well as the findings of other
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groups who have failed to confirm the association (Willis et al., 2016). These
factors may also impact parental interest in genetic counseling for pediatric
cancer predisposition syndromes.
1.3.1 Genetic counseling considerations
In addition to the factors identified by Willis et al., there are multiple
unique considerations in pediatric cancer genetic testing that are not applicable
in the adult cancer realm. For instance, genetic testing of minors is a highlydebated topic, and it is generally agreed among healthcare professionals that
genetic testing should not be pursued in minors unless the results would directly
impact clinical management. This concept is often boiled down to the question,
“is this testing in the best interest of the child?” (Kesserwan, Friedman Ross,
Bradbury, & Nichols, 2016). Pediatric cancer predisposition syndromes often blur
this line, as recommendations for surveillance and management of these
conditions have previously been institution specific, prior to the publication of
formal national guidelines. The best interest for the child can be interpreted in a
variety of ways depending on who is asking the question. Healthcare providers
and families have differing perspectives and will pull upon different beliefs to
make decisions regarding genetic testing.
Brozou et al. assessed interest in trio WES among parents of children
recently diagnosed with cancer. Of the 94 families invited to participate, 83
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(88.3%) consented to WES. Fear of the results was the most common reason for
refusal among the 11 families that chose not to participate. It was concluded that
knowledge of an underlying CPS is preferred by the majority of families
involved in their study (Brozou et al., 2017). In the genetic counseling
recommendations made by the AACR, Druker et al. stress the importance of pretest genetic counseling to ensure families have been given the information
required in order to truly provide informed consent (Druker et al., 2017).
Decisions about pursuing genetic testing should not only be made based on
medical relevance but also on the psychosocial impact testing and subsequent
changes in medical management may have on the patient and family. The age of
the child also plays a large role in the decision of whether to pursue genetic
testing. Whenever possible, the child should be included in the decision-making
process, and informed assent is often required from older children.
To further complicate the matter, genetic testing for CPS in childhood
could also provide risk information that is not relevant until adulthood. Some
cancer predisposition syndromes that present in childhood are caused by
biallelic mutations in adult cancer predisposition genes, such as those in the
mismatch repair (MMR) pathway. Heterozygous mutations in MMR genes are
consistent with a diagnosis of Lynch syndrome, an adult onset colorectal cancer
predisposition syndrome; however, biallelic mutations in an MMR gene are
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consistent with a diagnosis of constitutional mismatch repair deficiency
(CMMRD) which predisposes to multiple pediatric and adult cancer types.
Lynch syndrome can inadvertently be diagnosed in a child if CMMRD is
suspected and only one pathogenic mutation in a MMR gene is identified. It is
therefore critical to introduce the possibility of inadvertently diagnosing an
adult-onset condition in both the adult as well as the child during pre-test
counseling.
As next-generation sequencing becomes more affordable, many
institutions that care for children with cancer now include tumor genomic testing
as a tool to refine risk stratification and modify treatment. This process is often
initiated by the patient’s primary treatment team and usually does not include
the same informed consent process as germline genetic testing does. Tumor
testing, however, can uncover germline status either using a germline sample for
comparison or even based on allele frequency. Patterns of somatic mutations
within the tumor can also be suggestive of an underlying CPS such as tumor
hyper-mutation in individuals with a defect in the MMR pathway (Everett,
Mody, Stoffel, & Chinnaiyan, 2016). It has been debated whether these incidental
findings should be disclosed to patients and their families, especially when
obtained through research protocols (Kesserwan et al., 2016). In general,
researchers advocate incorporation of information about incidental germline
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findings into the pre-test counseling process for testing that utilizes NGS
technology (Kuhlen & Borkhardt, 2015). Lolkema et al. discuss the ethical, legal
and social implications of this matter in the adult oncology setting, supporting
return of clinically actionable results due to the ethical principle of the duty to
warn (Lolkema et al., 2013).
The process of results disclosure to the patient and family is also a
complex process and can be stressful. Schneider and Jasperson advocate honest
and age appropriate results disclosure, which is associated with better outcomes
(Schneider & Jasperson, 2015). In contrast to results disclosure in the adult
setting, the results of genetic testing in the pediatric oncology realm are disclosed
to the parents or guardians of the child; depending on the patient’s age, results
may not be initially given to them. Follow-up in adolescence is especially
important for children diagnosed with cancer predisposition syndromes as they
transition to managing their own care to ensure they are cognizant of their health
risks and potential risks to future children. Return of results after the death of the
patient also produces ethical dilemmas, although federal regulations, such as the
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule,
provide guidance in these situations. Scollon et al. also encourage discussion of
post-mortem results return during the pre-test counseling process (Scollon et al.,
2015). As results of genetic testing also have an impact on other family members
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including siblings and more distant relatives, this should be factored into the
results disclosure process regardless of whether the patient is living or deceased.
1.3.2 Attitudes toward presymptomatic genetic testing
The myriad of ethical considerations when deciding whether to pursue
genetic testing and how to approach results disclosure continue to challenge
health professionals and families. Although these are fundamentally personal
decisions for families, some case studies and professional commentary have
provided insight into decision-making about genetic testing in this population.
Evans et al., discusses factors influencing predictive genetic testing among two
families with Li-Fraumeni syndrome (LFS), caused by mutations in the TP53
gene. Between the two families who elected to pursue predictive TP53 testing in
childhood, parental anxiety was cited as the primary reason for pursuing testing
(Evans, Lunt, Clancy, & Eeles, 2010). Although genetic testing guidelines in
childhood discourage testing if the results would have no immediate impact on
medical management, Michael Parker discusses scenarios in which those
guidelines may be at odds with clinical judgement. Situations in which a
clinician’s judgement may support genetic testing for adult-onset conditions in a
minor include instances where it is believed that proceeding with genetic testing
will enhance the child’s well-being. This can include suspicion for an autosomal
recessive condition in which heterozygote carriers have increased adult cancer
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risks such as Fanconi Anemia and CMMRD (Parker, 2010). Physicians and other
healthcare providers must exercise caution when considering predictive testing
for cancer predisposition syndromes in childhood and will need to incorporate
the clinical judgement in the decision-making process.
Parental perceptions of predictive testing in pediatric oncology have been
explored among cohorts of individuals with a family history of familial
adenomatous polyposis (FAP), Li-Fraumeni syndrome, neurofibromatosis type 2
(NF2) and von Hippel Lindau (VHL). All four conditions predispose individuals
to cancer during childhood and have some screening options available to at-risk
individuals. Uptake of predictive testing in childhood for FAP, LFS, NF2 and
VHL was assessed in a study by Evans et al. (1997), which showed a 95% uptake
of genetic testing for those four conditions in children aged 10-16. Testing
specifically for VHL was pursued for children 5-9 years of age and the rate of
uptake in that group was 6 out of 18 (Evans, Maher, Macleod, Davies, &
Craufurd, 1997).
In a study of parental decision-making regarding genetic testing for
familial TP53 variants, Alderfer et al. found that most parents elected to pursue
genetic testing for their children at risk to inherit the variant. The perceived
advantages to testing cited in their study included a “need to know”, a desire to
understand why their child had cancer, and interest in research involvement.
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Perceived disadvantages, however, were primarily focused on psychosocial
concerns such as cancer worry and privacy or insurance concerns (Alderfer et al.,
2015).
Among parents of children at risk for FAP, factors influencing the decision
to pursue genetic testing included personalized medical management. Perceived
barriers to predictive FAP testing were insurance concerns in addition to lack of
provider recommendation, which underscores the importance of individualized
risk assessment and discussions of medical management for individuals who are
known to have FAP as well as those at risk (Levine et al., 2010). Although interest
in genetic counseling and testing have been studied in individuals at risk for
these well-known childhood cancer predisposition syndromes, these studies only
represent a small proportion of children diagnosed with cancer who may have
an underlying cancer predisposition syndrome.
1.4 Rationale
Although there are several publications regarding appropriate clinical
indications for genetics referral in pediatric oncology, the perceived utility of
genetic counseling from the parental perspective remains unknown. The
pediatric oncology subspecialty provides a unique set of genetic counseling and
testing considerations relative to other genetics specialties, including testing
minors for adult-onset conditions and the possibility of uncovering a germline
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cancer predisposition syndrome within the context of routine tumor testing.
These unique considerations in pediatric cancer genetic testing have been
discussed by genetics professionals; however, parental perspectives of genetic
counseling and testing for the pediatric cancer population have not been
explored.
1.5 Purpose
The purpose of this study is to assess desire for genetic counseling
services among parents of children with cancer, which can be used to inform
future genetic counseling referral practices in the pediatric oncology setting.
Information gleaned from this study will provide genetic counselors with a
better understanding of which patient/parent population(s) may be inherently
more receptive to pediatric cancer genetic counseling referral. The results will
also give a glimpse into the motivating factors in this group of families, as well as
provide crucial information about perceived barriers to genetic counseling
services, which in turn can be used to better meet the needs of this population.
Administration of the study survey will also serve to increase awareness of
genetic counseling and testing among both patients and pediatric oncologists.
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CHAPTER 2
INTEGRATING GENETIC COUNSELING AND TESTING IN THE PEDIATRIC
ONCOLOGY SETTING: PARENTAL ATTITUDES AND INFLUENCING
FACTORS1

Desrosiers, L.R., Quinn, E., Cramer, S. & Dobek, W. (2018) Integrating Genetic Counseling and
Testing in the Pediatric Oncology Setting: Parental Attitudes and Influencing Factors. (to be
submitted)
1
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2.1 Abstract
Cancer predisposition syndromes (CPS), caused by germline pathogenic
variants in tumor suppressor genes and oncogenes, are genetic conditions that
put an individual at increased risk to develop cancer. It is estimated that 10-15%
of children with cancer have an underlying CPS. Although genetic testing for
these conditions has become routine in the adult setting, incorporation of
germline genomic technologies into pediatric cancer care has not occurred as
rapidly. The purpose of this study is to assess desire for genetic counseling and
testing services among parents of children with cancer to provide parental
insight in the incorporation of genomic technologies in this health care setting.
Forty-two parents of individuals diagnosed with cancer less than 18 years of age
completed either a paper (n=8) or online survey (n=34) regarding their child's
cancer history, personal perspectives on genetic counseling, and
family/demographic information. Interest in genetic testing for CPS was variable,
with 50% of respondents indicating they would be interested in pursuing genetic
testing for their affected child while one-third of respondents indicated that they
were unsure if they would pursue genetic testing. The factors most commonly
cited as impacting interest in genetic counseling/testing include the potential for
modification of medical care for family members and for the child’s treatment
based on results. A subset of parents expressed that concerns for genetic

22

discrimination and potential negative impact on mental health would negatively
influence their interest in genetic testing for CPS. Genetic counselors have an
ideal skillset to help families weigh the benefits and drawbacks of genetic testing
for CPS in childhood to facilitate decision-making among this population as the
availability and clinical utility of genomic testing increases.
2.2 Introduction
Cancer predisposition syndromes (CPS) are conditions caused by
germline pathogenic variants that put an individual at increased risk to develop
cancer throughout their lifetime. CPS, also called hereditary cancer syndromes,
have been recognized since Alfred Knudson Jr.’s 1971 publication on hereditary
retinoblastoma and the two-hit hypothesis, but have become more widely
acknowledged due in part to articles about the BRCA1 and BRCA2 genes in
mainstream media as well as the availability of clinical genetic testing (Jolie,
2013; Knudson, 1971). Genetic testing for CPS has become increasingly integrated
into clinical care for adult patients, in large part due to advances in next
generation sequencing (NGS). However, these technologies have not been as
rapidly incorporated into routine pediatric cancer care.
Through studies of large cohorts of children with cancer using whole
exome sequencing (WES), it has been determined that approximately 10-15% of
children with cancer have an underlying CPS (Chang et al., 2016; Mody et al.,
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2015; Oberg et al., 2016; Parsons et al., 2016; Zhang et al., 2015). In addition to the
general prevalence of CPS, relationships have been established between specific
pediatric tumor types and germline genetic changes. For example,
retinoblastoma is highly associated with pathogenic changes in the RB1 gene,
with pathogenic variants identified in 15% of patients with unilateral
retinoblastoma and nearly 100% of patients with bilateral disease (Plon &
Nathanson, 2005). Despite the prevalence of CPS among patients with pediatric
cancers and the established associations between cancer types and specific
genetic changes, many medical centers do not yet have genetics professionals
integrated into their pediatric oncology departments.
Childhood CPS have, however, begun to receive more attention from the
medical community in the form of review articles published by Society for
Pediatric Oncology and Hematology as well as the National Society of Genetic
Counselors (Ripperger et al., 2017; Scollon et al., 2017). In addition to increasing
attention to these syndromes, several institutions have developed clinical
screening tools to identify individuals at risk for childhood cancer predisposition
syndromes that would justify referral to genetic counseling and/or clinical
genetics. These clinical screening tools incorporate tumor type, clinical features,
and family history with or without dysmorphology evaluation to select those
individuals that would be most appropriate for genetics referral (Goudie et al.,
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2017; Hopman et al., 2013; Jongmans et al., 2016; Postema, Hopman, de Borgie, et
al., 2017).
Although there are several publications regarding appropriate clinical
indications for genetics referral, the perceived utility of genetic counseling from
the parental perspective remains unknown. Formal guidelines for treatment and
management of specific CPS were published in the summer 2017 Clinical Cancer
Research Pediatric Oncology Series to promote uniformity of care in this patient
population (Brodeur et al., 2017). With the increasing attention on pediatric CPS,
studies have been done to assess provider interest in and comfort with
incorporating genetic/genomic testing into childhood cancer care. These studies
have demonstrated a lack of comfort with the process of genetic testing and an
interest in incorporating genetic counselors into this aspect of cancer care
(Johnson et al., 2017). Despite the push to incorporate genomic testing into
pediatric cancer care from the scientific and medical communities, little is known
about parental perspectives on this topic.
In addition to limited provider comfort and uncertainty surrounding
parent interest in these technologies, there are several other genetic counseling
considerations in the realm of pediatric cancer. Historically, genetic testing for
cancer predisposition and other adult-onset conditions in minors has been
discouraged due to the principles of autonomy and right to an open future
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(Kesserwan et al., 2016). Pediatric CPS genetic testing falls in an ethical greyzone, as genes implicated in childhood CPS overlap with adult-onset hereditary
cancer syndromes. Germline genetic status can also be identified incidentally
during routine tumor genetic profiling, which is used for risk assessment and
treatment decisions. This produces an ethical dilemma for providers in
determining whether to disclose these results to families since somatic tumor
testing does not have a rigorous consent process like germline genomic testing
(Everett et al., 2016).
As genetic testing for pediatric cancer predisposition syndromes becomes
more accessible, it will be critical incorporate the technology in a thoughtful
manner due to the associated ethical complexities. One step towards this end is
to gain a deeper understanding of parental attitudes toward genomic
technologies among the pediatric cancer population. The purpose of this study is
to assess desire for genetic counseling services including motivating factors and
perceived barriers to genetic counseling and testing among parents of children
with cancer. It is anticipated that most parents surveyed will be interested in
genetic counseling and/or testing for their child. Among the factors influencing
interest in pediatric cancer genetic counseling, it is expected that prior
knowledge of genetic counseling, desire for additional information regarding
medical management, and perceived cost will play the largest role in predicting
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parental desire for genetic counseling services. As one of the first steps to
promoting awareness of CPS among patients and providers, this research may in
turn promote access to specialized care for individuals with these rare pediatric
cancer predisposition syndromes in the future.
2.3 Materials and Methods
2.3.1 Design and Participants
Both paper and online surveys were conducted to assess attitudes towards
genetic counseling and testing among parents of children diagnosed with cancer
younger than 18 years of age. Participants were recruited in person at the
Palmetto Health Children's Center for Cancer & Blood Disorders clinic during
the check-in process for routine office visits. Eligible individuals were given a
copy of the questionnaire (Appendix A) as well as a participant resource sheet
that provided additional information about genetic counseling (Appendix B).
The online questionnaire (Appendix C) was posted on Facebook parent support
pages by representatives of “Alex’s Lemonade Stand Foundation”
(www.alexslemonade.org) and “St. Baldricks Foundation”
(www.stbaldricks.org) in order to maintain anonymity of the members of each of
these parent support pages.
Responses were collected from October 1st, 2017 until March 1st, 2018.
Inclusion criteria for participation consisted of individuals over 18 years old who
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are the parent or legal guardian of a child diagnosed with any type of cancer.
Any parents who were less than 18 years of age at the time of data collection
were excluded from participation. A total of forty-two responses were obtained
via paper (n=8) and online (n=34) versions of the questionnaire that met inclusion
criteria for the study. An additional 6 paper and 2 online survey responses were
obtained but did not meet the inclusion criteria because an insufficient number of
questions were answered (n=3), a cancer diagnosis was not indicated (n=2),
and/or a patient completed the questionnaire instead of a parent (n=4).
2.3.2 Instrument
The questionnaire consisted of twenty-four and thirty-four questions for
the paper and online versions respectively. Differences in the number of
questions were necessitated by the format of the online survey program
(SurveyMonkey), but the text was maintained between the two delivery models.
Survey items were divided into four sections comprising cancer history,
perspective on genetic counseling, information about your child/children, and
demographic information. The survey instrument was reviewed and edited by
all members of the committee prior to submission to the Institutional Review
Board (IRB). Informed consent was implied by completion of the questionnaire in
accordance with protocol approval by the University of South Carolina IRB
(Pro00067851).
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2.3.3 Data Analysis
Both quantitative and qualitative data were captured in survey responses.
Numerical and categorical responses from the questionnaire were analyzed
using descriptive statistics. Chi-square tests for association were used to
determine significance (p < 0.05) of the association between both patient and
parent demographics and parental perspectives on genetic counseling/testing.
Factors influencing interest in genetic counseling/testing were assessed using a
Likert-type scale (1=strongly disagree; 5=strongly agree) and were represented
with descriptive statistics. Lastly, responses to open-ended questions were
assigned themes and sub-themes by the principal investigator and reviewed by
the committee members.
2.4 Results
2.4.1 Demographic Information
Of the fifty individuals who initiated the questionnaire, data were
analyzed for the forty-two participants who both met the inclusion criteria and
responded to enough survey items (>50%). Demographic characteristics of the
participants are summarized in Table 2.1, which demonstrates that the sample
population consisted of mostly female (82.9%; n=34) and Caucasian (80.5%;
n=33) participants. Ages of the sample population ranged from 31 to 64 years,
with a mean age of 43.78 years. Most participants reported an education level of
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Table 2.1 Demographic characteristics of study participants.
Characteristics
Sex (n=41)
Male
Female
Age (n=40)
31-40y
41-50y
51-60y
61-70y
Race/Ethnicity (n=41)
Caucasian
Hispanic/Latin American
Black
Asian/Pacific Islander
Biracial
Education Level (n=41)
Some high school
High school or GED
Some college
Associate degree
Bachelor degree
Graduate degree
Annual Household Income (n=41)
Less than $25,000
$25,001-$50,000
$50,001-$75,000
$75,001-$100,000
More than $100,000
Prefer not to respond
Region of Residence (n=40)
Northeast
Southeast
West

Frequency

Percent

7
34

17.1%
82.9%

16
17
6
1

40.0%
42.5%
15.0%
2.5%

33
1
3
2
2

80.5%
2.4%
7.3%
4.9%
4.9%

1
1
8
4
11
16

2.4%
2.4%
19.5%
9.8%
26.8%
39.0%

3
3
7
10
14
4

7.3%
7.3%
17.1%
24.4%
34.1%
9.8%

16
15
9

40.0%
37.5%
22.5%
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a Bachelor’s degree or higher (65.8%; n=27) and annual household income greater
than $75,000 (58.5%; n=24); however, all education levels and annual income
categories were represented in the sample. Most participants also reported that
they are married (77.5%; n=31). Fifteen different states of residence were
reported, with most participants residing in the northeast [CT, NJ, NY, PA and
RI] (40.0%; n=16) or southeast [FL, GA, NC, SC and VA] (37.5%; n=15) United
States. Due to the limited number of participants from states that are not on the
east coast, the remaining states were categorized as west [AZ, CA, HI, WA and
WI] (22.5%; n=9).
2.4.2 Cancer Diagnoses
Participants were asked to provide information about their child who was
diagnosed with cancer, which is summarized in Table 2.2. Among the reported
childhood cancer diagnoses, most affected individuals were male
(64.3%; n=27). Average age at diagnosis was 5.26 years, ranged from 1 to 16
years, and most children were living at the time of the study (88.1%; n=37). On
average, children were 6.71 years from diagnosis; however, time since diagnosis
ranged from 0-19 years. The cancers reported by participants via a free-text
response were sorted into three categories: hematologic (35.7%; n=15), nervous
system (38.1%; n=16) and solid cancers (26.2%; n=11) that were approximately
equally represented. In addition, two children were diagnosed with more than
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Table 2.2 Cancer history and demographic characteristics of the child[ren]
diagnosed with cancer.
Characteristics
Sex (n=42)
Male
Female
Age at Diagnosis (n=41)
Infancy
Toddler
Preschool
Early Childhood
Middle Childhood
Adolescence
Current Age (n=35)
Toddler
Preschool
Early Childhood
Middle Childhood
Adolescence
Adult
Living or Deceased (n=42)
Living
Deceased
Cancer Type (n=42)
Hematologic Malignancies
Solid Tumor
Nervous System Tumor
Number of Malignancies (n=42)
One
Two or More
Siblings (n=41)
None
One
Two or more
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Frequency

Percent

27
15

64.3%
35.7%

4
9
8
13
1
6

9.8%
22.0%
19.5%
31.7%
2.4%
14.6%

1
2
10
7
11
4

2.9%
5.7%
28.6%
20.0%
31.4%
11.4%

37
5

88.1%
11.9%

15
11
16

35.7%
26.2%
38.1%

40
2

4.8%
95.2%

8
18
15

19.5%
43.9%
36.6%

one cancer. Participants also provided information about other medical and/or
special needs of their child with cancer. Of the 42 children with cancer, 57.1%
(n=24) have no additional medical needs aside from cancer treatment. The
remaining 18 children had a total of 26 pre-existing or treatment-related health
complications depicted in Figure 2.1, the most common of which was learning
difficulties (n=7).
Information about cancers in first degree relatives (FDR) and second
degree relatives (SDR) of the child with cancer was also collected and outlined in
Table 2.3. Of all participants, 64% reported that their child had a family history of
cancer (n=27). Two participants reported a family history of other childhood
cancers; these were acute lymphoblastic leukemia and choroid plexus carcinoma.
Approximately 10% of respondents (n=4) indicated that a parent or sibling of
their child was diagnosed with cancer <45 years of age, and 26% (n=11) reported
a grandparent, aunt, or uncle was diagnosed with cancer <45 years of age.
Among first and second-degree relatives, the most common cancer type was
breast cancer (n=8) followed by prostate (n=3) and skin (n=2) cancers. Multiple
other cancer types were indicated in family members, and five participants
provided history for more distant relatives such as third and fourth degree in the
free-text question responses.
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4%

4%

Growth restriction

8%

Developmental Delay

4%
11%

Learning Difficulties
Intellectual Disability

11%

Skin findings
Frequent infections
4%

Treatment-related complications
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Allergies and Asthma

4%

Crohn's disease
27%
Hearing loss
11%

Type 1 diabetes
4%

Fatigue
4%

4%

Mental illness

Figure 2.1 Other reported medical and/or special needs of the children with cancer.

Table 2.3 Family history characteristics of the children diagnosed with cancer.
Family History Characteristics
Reported Family History
1 or more childhood cancers
1 or more FDR with cancer <45 years
2 or more SDR with cancer <45 years
Childhood Cancers
Acute lymphoblastic leukemia
Choroid plexus, brain tumor
FDR Cancer Type
Breast
Sarcoma
Lymphoma
Thyroid
Skin
SDR Cancer Type
Breast
Prostate
Brain
Skin
Leukemia
Ovarian
Jongmans Criteria
Meets Criteria
Does not meet criteria
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Frequency

Percent

2
4
11

4.8%
9.5%
26.2%

1
1

2.4%
2.4%

2
1
1
1
1

33.33%
16.67%
16.67%
16.67%
16.67%

6
3
1
1
1
1

46.15%
23.08%
7.69%
7.69%
7.69%
7.69%

18
24

42.9%
57.1%

The five criteria for genetics referral proposed by Jongmans et al. (2016)
were used to determine those participants most likely to benefit from cancer
genetic counseling and/or testing. These criteria include: (1) family history of
cancer, (2) specific cancer types, (3) two or more malignancies, (4) other
anomalies or features, and (5) excessive treatment toxicity (Jongmans et al., 2016).
Information from participant report was used to determine whether the criteria
were met. Based on the information provided about the child and family’s cancer
histories, 42.9% (n=18) of participants met the referral criteria outlined in
Appendix D.
In addition to cancer history, participants were asked about medical
conditions for their other children. In contrast with the 42.9% (n=18) of children
with cancer who had additional medical and/or special needs, 9.6% (n=4)
reported the child with cancer had a sibling with additional medical and/or
special needs. These included 2 individuals with autism spectrum disorder, 1
with chronic sinus infections due to nasal polyps, and 1 with von Willebrand
disease.
2.4.3 Perspective on Genetic Counseling
Prior awareness, experience and interest in genetic counseling was
assessed in the section of the questionnaire that followed the child’s cancer
history, which is summarized in Figure 2.2. Many participants (64.3%; n=27)
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A

B

C

5%

5%
36%

31%

32%
51%

64%

59%
17%

Yes

Yes

Yes

No

No

No

Unsure

Offered, but declined

Unsure

Figure 2.2 Participant perspectives on genetic counseling and/or testing. (A)
knowledge of genetic counseling prior to participation in the study; (B)
previous experience with genetic counseling and/or testing regardless of
specialty; (C) reported interest in genetic testing for hereditary cancer for their
child.
reported awareness of genetic counseling prior to participating in the
questionnaire. Of the individuals who reported prior awareness, 17 participants
reported that they were offered genetic counseling (40.5%), two of which
declined (4.8%). The reasons for genetic counseling referral were provided via
free-text response and assigned one of the three common referral indications:
prenatal, cancer or general genetics. Most participants who were offered genetic
counseling reported the referral indication as cancer (52.9%; n=9); however,
others reported either prenatal (29.4%; n=5) or general (17.6%; n=3) indications
for genetics referral. Examples of non-cancer related referrals included advanced
maternal age, testing for chromosome conditions during pregnancy, and
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evaluation for Marfan syndrome. These non-cancer related indications accounted
for 47.0% of genetic counseling referrals reported among participants.
Participants were also asked about their interest in genetic counseling for
their child’s cancer history. While half (50.0%; n=21) of participants reported
interest in pursuing genetic counseling and/or testing for pediatric cancer
indications, 31.0% (n=13) of participants reported they were unsure. Less than
20% (n=7) of participants reported no interest in genetic testing.
2.4.4 Factors Influencing Interest in Genetic Counseling/Testing
In addition to general interest in pursuing genetic testing, participants
were presented with seven statements about factors that might influence their
interest in genetic counseling/testing. For each statement, participants were
asked to rank the level of influence that the factor would have on their interest in
pursuing genetic counseling/testing. Each statement had a range of responses on
a numerical scale from 1-5; the averages of responses were all greater than 3
(Figure 2.3). The statement with the highest mean score was “if it would impact
my family members’/my own healthcare” (mean = 4.64), while “If my child’s
treatment was complete” had the lowest mean at 3.38.
Participants were also asked what the ideal age would be for pursuing
genetic counseling and testing for their child. Over one-third of participants
(40.5%; n=17) did not provide any insight into their ideal age for genetic
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If it would impact my family members’/my
own healthcare
If the information might affect my child’s
treatment
If my doctor recommended it
If the test was free/low cost
If I could use the information for family
planning
If my child was older
If my child’s treatment was complete

0

1

2

3

4

5

6

Average Rating
Figure 2.3 Average ratings of factors influencing interest in genetic
counseling/testing (1=strongly disagree; 5=strongly agree).
counseling/testing. Of participants that responded to the question about timing
(n=25), 28.0% indicated uncertainty (n=7). Most responses did not specify a
certain age range, rather they indicated that testing could be pursued at any age
(n=5) or when needed (n=7) which accounts for 48.0% of responses. Of those that
specified a certain age range, there was not a clear preference for testing in
childhood (7.1%; n=3) or waiting until adulthood (4.8%; n=2).
Trends emerged between groups regarding interest in genetic counseling
and/or testing with three different demographic factors. These factors were the
child’s age at diagnosis, sex of the child, and the average household income. A
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chi-square test for association was conducted that demonstrated a statistically
significant association between the child’s age at diagnosis and interest in genetic
counseling (p=0.021). Interest in genetic counseling among each age group at
diagnosis is represented in Figure 2.4. The highest proportion of parents who
were interested in genetic counseling/testing was among parents of children
diagnosed as toddlers (35.0%), whereas parents of children diagnosed as
adolescents accounted for the smallest proportion of those interested in genetic
counseling (10.0%). The greatest uncertainty regarding interest in genetic
counseling/testing was among parents of children diagnosed in early childhood
(66.7%). None of the parents of children diagnosed in infancy or as toddlers
14

Frequency (n=39)

12
10
8
6
4

2
0
Infancy

Toddler
Yes

Preschool
No

Early
Adolescence
Childhood

Unsure

Figure 2.4 Relationship between age of the child's cancer diagnosis and
interest in genetic counseling/testing.
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reported that they were not interested in pursuing genetic counseling and/or
testing. Age at diagnosis was compared with participant ranking of the
statement “I would be interested in genetic counseling if my child was older.”
However, no statistical significant association was identified between the two
variables. In contrast with the statistically significant association between age at
diagnosis and interest in genetic counseling/testing, there was no evidence of an
association between the child’s current age (p=0.60), or the duration of time since
diagnosis (p=0.80) and interest in genetic counseling/testing.
Another statistically significant finding by chi-square test for association
was between the child’s sex and interest in genetic counseling (p=0.039). Interest
in genetic counseling stratified by child’s sex is illustrated in Figure 2.5. Parents
of female children with cancer were more likely to be interested in genetic
counseling/testing (52.4%) than parents of male children with cancer (47.6%).
Lack of interest in and uncertainty about genetic counseling/testing were more
common among parents of male children with cancer. All the individuals who
reported that they were not interested in genetic counseling/testing were parents
of male children with cancer. Of those that reported uncertainty regarding
genetic counseling/testing, 69.2% were parents of males with cancer. The child’s
sex was compared with participant ranking of the statement “I would be
interested in genetic counseling if I could use the information for family
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Frequerncy (n=41)

25
20
15
10
5
0
Male

Female
Yes

No

Unsure

Figure 2.5 Relationship between the child's sex and interest in genetic
counseling/testing.
planning.” However, no statistical significant association was identified between
the two variables.
Participant annual income also demonstrated a statistically significant
association with interest in genetic counseling and/or testing (p=0.050). Interest in
genetic counseling broken down by annual income is illustrated in Figure 2.6. A
higher proportion of individuals who replied “Yes” regarding interest in genetic
counseling/testing reported annual income less than $100,000 (70.0%) as
compared with those who reported annual income greater than $100,000 (30.0%).
In contrast, 35.7% of participants who reported annual income greater than
$100,000 indicated that they were not interested in pursuing genetic
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Frequency (n= 36)

25
20
15
10
5

0
< $100,000
Yes

> $100,000
No

Unsure

Figure 2.6 Relationship between participant annual income and interest
in genetic counseling/testing.
counseling/testing, which accounted for 83.3% of the total respondents who
replied “No” regarding interest in genetic counseling/testing. There was no
statistical association between annual income and participant responses to the
statement “I would be interested in genetic counseling if the test was free/low
cost.” No statistically significant difference in prior knowledge of or experience
with genetic counseling was identified between participants who made less than
or equal to $100,000 and greater than $100,000 annually.
Chi-square tests for association were done for all other demographic
factors and interest in genetic counseling/testing except for participant sex, race,
marital status and type of health insurance due to the limited diversity of
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responses in these categories. These analyses showed no statistically significant
associations. Of note, interest in genetic counseling/testing appeared to be
independent from whether the child met the Jongman’s criteria for genetics
referral (p=0.981). No statically significant association was observed between
prior knowledge of genetic counseling and interest (p=0.668).
2.4.5 Thematic Analysis
Within the questionnaire, participants were asked to provide their thoughts
regarding genetic counseling and testing for pediatric cancer predisposition in a
free-text format. Of the total participants, 50% (n=21) responded to this question;
however, two of the responses were excluded from thematic analysis because
they did not provide insight into their reasoning for or against interest in
pursuing genetic testing. Themes are broken down into motivators and barriers,
which are then further broken down into sub-themes. The sub-themes are
organized by observation frequency, which is demonstrated in Table 2.4 and
Figure 2.7. Select quotations are provided to illustrate each theme.
2.4.5.1 Motivators for genetic counseling and/or testing.
Most participants who responded to the free-text question described
positive factors influencing their interest in genetic counseling and/or testing
(n=14). Among the responses, two distinct themes emerged: (1) general
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Table 2.4 Themes and sub-themes regarding interest in genetic counseling/
testing identified through free-text question responses.
Theme
Motivators for Genetic
Counseling and/or
Testing

Barriers to Genetic
Counseling and /or
Testing

Sub-themes
General knowledge for family members or other
individuals
Potential utility in treatment, surveillance and/or
planning for the child’s future
Perceived susceptibility to genetic discrimination
in health insurance/employment or issues of
confidentiality
Concerns regarding impact of genetic testing
results on mental health
Cost prohibitive nature of genetic/genomic testing

12

Frequency (n=19)

10

10

8
6
4

4

3

2

1

1

0
Knowledge for Treatment/
Genetic
Mental Health
others
Surveillance Discrimination/
Confidentiality
Motivators

Cost

Barriers

Figure 2.7 Frequency of sub-themes identified through analysis of the
free-text question responses.
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knowledge for family members or other individuals, and (2) potential utility in
treatment, surveillance, and/or planning for the child’s future.
Theme 1: General knowledge for family members or other individuals
The most commonly described factor influencing interest in genetic
counseling and testing among free-text responses was the desire for knowledge
that could help others. Over 50% (n=10) of the free-text responses for this
question drew upon the theme of knowledge for others. Some individuals
mentioned an interest in gaining the information for their immediate family,
while others touched on the desire to help other individuals such as through
research.
“I would be willing to do it if it helped my family or anyone else”
Theme 2: Potential utility in treatment, surveillance and/or planning for the child’s
future
Several individuals highlighted how information gained through genetic
counseling and/or testing could be useful for their child’s future. Participants
expressed uncertainty and concern for their child’s future, mentioning that
information gained from genetic testing may help them to determine appropriate
surveillance.
“I want to know if my sons [sic] cancer has a genetic link or if he holds a
predisposition for other cancers. It would allivieate [sic] some of our fears and
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worry. What if we stop scanning and he gets cancer again? We might not know
till it’s too late. If we had genetic testing we would know what to do for the
future.”
Others highlight the desire for additional information about options for
cancer prevention.
“If we could have learned earlier about risks or possible preventative measures, we
would have participated.”
2.4.5.2 Barriers to genetic counseling and/or testing.
Approximately a quarter (n=5) of responses to the free-text question
identified barriers to genetic counseling or testing in this population. Three
themes emerged including: (1) perceived susceptibility to genetic discrimination
in health insurance/employment or issues of confidentiality, (2) concerns
regarding impact of genetic testing results on mental health, and (3) cost
prohibitive nature of genetic/genomic testing.
Theme 1: Perceived susceptibility to genetic discrimination in health
insurance/employment or issues of confidentiality
A topic of concern brought up by participants (n=3) was the potential for
genetic discrimination and issues of confidentiality. One participant discussed
their fears that genetic information could be used to deny health insurance
coverage for treatment, saying:
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“…Also concerned about health insurance companies misusing the information to
deny treatment or coverage.”
Another parent brought up the sensitivity of genetic information in our
current society, which is contrasted by their desire to contribute to medical
knowledge.
“I understand the value of pooling genetic information, but security and
confidentiality can no longer be guaranteed in our society. Sharing personal
information without a definite benefit and the distinct possibility of adverse
consequences make it hard to do.”
Theme 2: Concerns regarding impact of genetic testing results on mental health
The subject of mental health implications of genetic testing results was
also a concern identified by a participant.
“cloud hanging over your head and might affect mental health and outlook on
life.”
Theme 3: Cost prohibitive nature of genetic/genomic testing
Genetic testing can not only be taxing on financial resources, but also
other resources such as tumor tissue as was identified by one participant:
“We didn't pursue due to cost and because they don't have much left of the tumor
so we wanted to save it in case he needs treatment in the future.”
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Overall, participants provide more insight into the motivating factors
(n=14) relative to insight about barriers (n=5).
2.5 Discussion
The incorporation of genetic and genomic testing in pediatric oncology has
lagged in its adoption in the adult oncology setting; however, recent research has
supported the clinical utility of NGS technologies in the pediatric population. A
study of provider comfort with genomic testing demonstrated a lack of comfort
and an interest in incorporating genetic counselors into the testing process
(Johnson et al., 2017). Genetic counselors are trained in providing education and
genetic risk assessment, and can serve as a resource for families in the decisionmaking process surrounding genetic testing.
2.5.1 Parental Attitudes Towards Genetic Counseling
It was hypothesized that most participants would be interested in genetic
counseling/testing; however, only half responded that they were interested in
pursuing genetic testing for their child. The participant population demonstrated
more uncertainty regarding interest in genetic testing for their child than was
expected, with 31.0% reporting they were unsure of their interest. Genetic
counselors have an ideal skillset to assist families who are contemplating
whether to pursue genetic testing for their child by providing information and
support in the decision-making process. Of all participants, 16.7% reported that
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they were not interested in genetic testing. However, genetic counseling may still
be beneficial as their reasoning for lack of interest was not clearly established
through this study. Research by Brozou et al. demonstrated a much higher rate of
uptake of WES in families of children with cancer at 88.3%. However, this was
assessed after the WES consent process, so it may be that the counseling process
alleviated uncertainty leading to uptake of WES (Brozou et al., 2017).
No clear consensus was reached in the sample about an optimal age or
timing for genetics referral. Forty-eight percent of participants who responded to
the question about timing indicated that genetic testing should be performed
either "when needed" or "at any time". Therefore, the results from this study
suggest that parental preference regarding timing is not contrary to the genetic
counselor recommendations provided by Druker et al. in the AACR Pediatric
Oncology Series, which encouraged referral at the time of diagnosis (Druker et
al., 2017).
Interest in genetic testing for cancer predisposition syndromes (CPS)
among this population was independent of personal or family history
characteristics suggestive of a CPS as defined by the Jongmans criteria for
genetics referral. It is potentially reasonable then, to offer genetics referral
regardless of history, as other research has suggested that family history may not
be a reliable tool in assessing the likelihood of a CPS. In a study by Zhang et al.,
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only a minority of individuals with a germline pathogenic variant in a gene
associated with a known CPS had a suggestive family history (Zhang et al.,
2015). Age-related penetrance of CPS and the potential for de novo mutations,
especially in syndromic forms of CPS, may impact the utility of family history in
genetic risk assessment for pediatric CPS.
2.5.2 Factors Influencing Attitudes Toward Genetic Counseling
Contrary to the hypothesis, no statistically significant association was
observed between prior knowledge of genetic counseling and interest in
pursuing genetic counseling/testing for pediatric CPS. Factors that show
statistically significant association with interest in genetic testing were the child’s
age at diagnosis and sex, as well as the participant’s annual household income.
There was a trend towards decreased interest in genetic testing as the child’s age
at diagnosis increased. These findings are inconsistent with results from a 1997
study, which showed uptake of predictive testing for FAP, LFS, NF2 and VHL
was 95% among children 10-16 years of age, while uptake of VHL testing from
ages 5-9 was only 6 out of 18 (Evans et al., 1997). It is difficult to ascertain why
these findings were inconsistent. However, the differences between predictive
and diagnostic testing as well as the time since publication of the study by Evans
et al. may be contributory.
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Another factor associated with interest in genetic testing was the child’s
sex. None of the parents of female children diagnosed with cancer indicated that
they were not interested in genetic testing. It was hypothesized that this may be
due to the potential use of genetic information in the child’s family planning,
although no statistical significance was found with the statement “I would be
interested in genetic counseling if I could use the information for family
planning.” Since this statement was aimed at participant (i.e. the parent) as
opposed to their child, it cannot be assumed that participants were not interested
in pursuing genetic testing for the child’s future family planning. Other studies
have demonstrated similar associations between uptake or interest in genetic
counseling/testing and sex in both the adult and pediatric cancer populations
(Evans et al., 1997; Willis et al., 2016).
Annual income was also a factor that influenced interest in genetic testing.
However, instead of increased interest with higher annual income as expected,
an inverse association was observed. Prior knowledge of or experience with
genetic counseling and/or testing did not differ significantly between income
groups and thus cannot account for the identified association between income
and genetic counseling/testing interest. In addition, there was not a statistically
significant association between annual income and ranking of the statement “I
would be interested in genetic counseling if the test was free/low cost.” The sub-
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theme “cost prohibitive nature of genetic/genomic testing” was only identified in
one free-text response, which was less than expected. What then, are the factors
that influenced the disparate interest levels between participants in the over
$100,000 and under $100,000 groups? It may be that individuals who have an
annual household income greater than $100,000 have a heightened concern for
the potential for genetic discrimination and concerns of confidentiality. The
“perceived susceptibility to genetic discrimination in health
insurance/employment or issues of confidentiality” sub-theme was the most
identified barrier to genetic counseling and testing among free-text responses.
Further research would be useful to clarify which factors influence the observed
reduction of interest among parents with an annual income greater that $100,000.
Among the factors influencing interest in genetic counseling/testing
assessed via the Likert-scale, the two with the highest average ranking were “if it
would impact my family members’/my own healthcare” and “if the information
might affect my child’s treatment.” These echo the sentiment identified by
multiple individuals in the free-text responses. Themes observed from the freetest responses focused on the utility of genetic testing results for the child, their
family, and others. Many individuals indicated that they would be interested in
pursuing genetic counseling/testing if the information could be used to help
family members. Others discuss the merits of general knowledge and/or the
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benefits for research purposes. Several participants mentioned their interest in
the ability to use information from genetic counseling/testing for their child’s
treatment and surveillance.
2.5.3 Implications for Practice
Parental perspectives on genetic counseling and testing in the pediatric
cancer population gained from this study complement the pre-existing medical
literature on CPS in childhood. Results from this study support the perceived
utility of genetic counseling and testing by parents of children diagnosed with
cancer as well as the perceived barriers to uptake of these technologies. Genetic
counselors have specialized training that can be used to engage families and
assist in weighing the benefits and drawbacks of genetic testing for CPS in
childhood. Parental interest in genetic/genomic technology, previously
demonstrated lack of provider comfort, and the currently limited number of
pediatric cancer genetics professionals support further expansion of genetics
professionals into childhood cancer care.
2.6 Limitations and Future Studies
2.6.1 Study Limitations
A major limitation of this study was the small sample size and homogenous
participant population. Initially, the survey was administered solely on paper in
the Palmetto Health Children's Center for Cancer & Blood Disorders clinic to
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obtain a participant population that is representative of families impacted by
pediatric cancer in South Carolina. Due to a low response rate, an online version
of the questionnaire was generated and distributed via Facebook parent support
pages. The smaller subset of participants that responded via paper questionnaire
showed more diversity in multiple demographics categories. Due to the
homogeneity of participant demographics, several demographic categories were
excluded from chi-square association tests. These categories included participant
sex, race, educational level, and marital status.
In addition to sample size, another unanticipated limitation was the
wording certain questions, such as those in the Likert-scale. It is possible that no
associations were found between responses to the Likert-questions and the
statistically significant associations between genetic counseling/testing interest
and child’s age/child’s sex, since the Likert questions were directed at the
participant rather than their child with cancer. Due to the question wording,
factors influencing desire for genetic counseling/testing as they relate to the child
with cancer may not have been accurately assessed.
2.6.2 Future Studies
As there were significant limitations regarding sample size, these research
questions should be assessed again in a larger and more diverse population. This
may be feasible through recruitment in a larger pediatric cancer treatment center.
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It would also be informative to compare interest in genetic testing prior to and
after pre-test counseling to see how counseling impacts participant interest in
pursuing genetic testing. Additional research questions that can be considered
include referral timing in the context of the cancer treatment process, as well as
investigation into why certain groups are less receptive to genetic counseling and
testing, such as families who make greater than $100,000 annually. It would also
be prudent to investigate the association between age at diagnosis and interest in
genetic counseling/testing as it relates to the child’s autonomy. This information
is critical for genetic counselors to optimize the information and support
provided to families throughout the genetic testing process. For the individuals
who reported uncertainty about pursuing genetic testing, qualitative studies may
illuminate the primary source(s) of ambivalence. In turn, these insights will
enable genetic counselors to better engage these families in their decision-making
processes.
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APPENDIX A – PAPER QUESTIONNAIRE
The following coversheet and questionnaire were distributed to
participants in the Palmetto Health Children's Center for Cancer & Blood
Disorders clinic.
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PARENTAL INTEREST IN GENETIC
COUNSELING IN THE PEDIATRIC
ONCOLOGY SETTING.
PURPOSE AND BACKGROUND:
You are being asked to volunteer for a research study conducted by Lauren Desrosiers, a
graduate student in the Department of Genetic Counseling at the University of South
Carolina. The purpose of this study is to assess interest in genetic counseling among parents
of children diagnosed with cancer. You are being asked to participate in this study because
your child has a current or previous diagnosis of cancer.
PROCEDURES:
If you agree to participate in this study, you will be asked to complete a questionnaire
about your familiarity with and interest in genetic counseling, although no prior knowledge
of genetic counseling is required. You will also be asked to provide information about your
family, including your child’s medical history pertaining to their diagnosis of cancer. Upon
completion of the questionnaire, please return study materials to a member of the clinic
staff.
DURATION:
Participation in the study will take approximately 5-15 minutes.
PAYMENT TO PARTICIPANTS:
You will not be paid for participating in this study.
VOLUNTARY PARTICIPATION:
Participation in this research study is voluntary. You are free not to participate, or to stop
participation at any time, for any reason without negative consequences. You are not
required to answer any question you do not wish to answer. In the event that you do
withdraw from this study, the information you have already provided will be kept in a
confidential manner.
If you have any questions, please contact Lauren Desrosiers by phone (803-545-5775) or
email (lauren.desrosiers@uscmed.sc.edu).

If you are willing to be contacted for future research please provide your name and contact
information below.
Name: _____________________________________________________________________
Phone: ____________________ Email: __________________________________________
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Cancer History
Please answer the following questions regarding your child who has/had cancer.

1. What is the gender of your child?
Male
Non-binary
Female
Prefer not to respond
2. What type of cancer were they diagnosed with? _________________________________
3. How old was your child when they were diagnosed with cancer? _________
4. Has your child been diagnosed with more than one cancer? If yes, what other cancers?
Yes; Please specify type(s) and age(s) at
No
diagnosis: __________________________________
5. Is your child living or deceased?
Living: Current Age _____
Deceased: Age of Death: ______
6. Does your child have any medical concerns or special needs besides cancer? Please provide details on the lines
provided.
Birth Defect(s):___________________________
Intellectual Disability
Growth restriction
Skin differences: _____________________________
Overgrowth
Blood condition(s): ___________________________
Developmental Delay
Frequent infections
Learning Difficulties
Other: _____________________________________
7. Is there a history of cancer in the family?
Yes
No
8. If you selected “Yes” for question 7 above, please select all that apply. Please also provide the type of cancer and
age at diagnosis for each selection made below.
There are 1 or more cancers in childhood (younger than18 years old): ___________________________________
Your child has a parent or sibling with cancer less than 45 years of age: _________________________________
There are 2 or more grandparents or aunts/uncles with cancer diagnosed before 45 years of age (on the same
side of the family): _______________________________________________________________________________
Perspective on Genetic Counseling
Genetic counselors are trained health care workers that help people understand the role of genetic factors in disease. They use family
and personal medical histories to determine a person’s risk of having a genetic change that would increase their chance of having
cancer. These changes can cause hereditary cancer syndromes, which may explain why a person developed cancer, and can also give
risk information for family members.

9. Have you heard of genetic counseling before beginning this survey?
Yes
No
Unsure
10. Have you or your child had genetic counseling or genetic testing before? (Please select the best answer)
Yes: For what reason? _____________________
I was offered genetic counseling or testing, but chose
not to accept: For what reason?
No
_____________________________________________
Unsure
11. Is genetic testing for hereditary cancer something you would be interested in pursuing for/with your child?
Yes
No
Unsure
12. Please indicate how each of the following statements would impact your interest in genetic counseling or testing
with 1=strongly disagree and 5=strongly agree. I would be interested in genetic counseling…
Strongly Disagree
Strongly Agree
1
2
3
4
5
i. If my doctor recommended it
ii. If the information might affect my child’s treatment
iii. If it would impact my family members’/my own healthcare
iv. If I could use the information for family planning
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v. If my child was older
a. What is the best age for genetic counseling or testing? __________
vi. If my child’s treatment was complete
vii. If the test was free/low cost
viii. Other, please specify: ____________________________
13. Please share any thoughts you have about your reasoning for/against pursuing genetic counseling or testing.
_______________________________________________________________________________________________
_______________________________________________________________________________________________
Information about your child/children
Please answer the following questions about all of your children.

14. How many children do you have? __________
15. How old are your children? Please provide ages for each of them. _________________________________________
16. Do any of your other children have medical concerns or special needs besides cancer? Please provide details on the
lines provided.
Birth Defect(s):___________________________
Intellectual Disability
Growth restriction
Skin differences: _____________________________
Overgrowth
Blood condition(s): ___________________________
Developmental Delay
Frequent infections
Learning Difficulties
Other: _____________________________________
Demographic Information
Please complete the following questions. This section helps to classify responses among subsets of the population and will not be
used in any attempts to identify you.

17. What is your gender?
Male
Female

Non-binary
Prefer not to respond

18. How old are you? _____
19. What race do you most identify with? (Mark all that apply)
Caucasian
Asian/Pacific Islander
Hispanic/Latin American
American Indian or Alaskan Native
African-American
Other, Please specify: _________________________
20. What is the highest level of education you have completed?
Some high school
Some college
Bachelor degree
High school or GED
Associate degree
Graduate degree
21. Which of the following best describes your current relationship status?
Married
In a domestic partnership or civil union
Divorced/Separated
Single, but living with a significant other
Widowed
Single/Never married
22. What was your total household income last year?
Less than $25,000
$50,001-$75,000
More than $100,000
$25,001-$50,000
$75,001-$100,000
Prefer not to respond
23. What is your zip-code? __________
24. What type of health insurance do you have for your child(ren)?
Private insurance plan (Ex. Aetna, Cigna, etc.)
Other, Please specify: _________________________
Medicaid/Medicare
No Insurance
Thank you! This concludes the survey. We appreciate your participation. Please refer to accompanying flyer for more details on
hereditary cancer and genetic counseling.
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APPENDIX B – PARTICIPANT RESOURCES
The following participant resources sheet was distributed to interested
participants in the Palmetto Health Children's Center for Cancer & Blood
Disorders clinic. It was also distributed electronically to individuals who were
recruited through a Facebook post.
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What is Hereditary Cancer?
Most cancers are considered sporadic, which means that they happen by
chance. Unlike sporadic cancer, hereditary cancers are those that happen
because of a genetic change a person is born with that makes them more likely
to develop cancer. There are many genes that help our bodies prevent cancer,
and changes in those genes can make a person more susceptible to cancer.
Researchers have found that up to 10% of children with cancer have a gene
change that increased their risk of developing cancer. On their own, genetic
changes do not guarantee that a person will develop cancer, but knowing
about these can help doctors recommend ways to modify environmental
factors or detect cancer earlier.

What is a Genetic Counselor?
Genetic counselors are trained health care workers that help people
understand the role of genetic factors in disease. They use family and personal
medical histories to determine a person’s risk of having a genetic change that
would increase their chance of having cancer. These changes can cause
hereditary cancer syndromes, which may explain why a person developed
cancer, and can also give risk information for family members. Cancer genetic
counselors help families to decide whether genetic testing for these types of
changes is right for them.

Additional Information
If you are interested in additional information about genetic counseling and/or
testing please see the “Locate a Genetic Counselor” section on the back of this
document. You may also speak with your child’s physician, or contact the
University of South Carolina Genetic Counseling department at 803-545-5775
with additional questions.
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Locate a Genetic Counselor
If at any point during this questionnaire you became concerned about your
child’s chance of having a genetic mutation that would increase their risk of
having cancer, consider contacting a genetic counselor by following the steps
below:
1. Go to the National Society of Genetic Counselors website homepage at:
www.nsgc.org
2. On the NSGC homepage, click the link titled, “Find a Genetic Counselor”

3. Enter your postal code and make sure to click “Cancer” under specialization.
Then, click search!
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APPENDIX C – ONLINE QUESTIONNAIRE
The text below was used to recruit participants via Facebook support
groups. Staff members from “Alex’s Lemonade Stand Foundation” and “St.
Baldricks Foundation” were asked to post this email on the support pages on my
behalf in order to protect the privacy of members.
“Hello,
My name is Lauren Desrosiers and I am a master's candidate in the
University of South Carolina genetic counseling training program. For my
master's research project, I am studying interest in genetic counseling
among parents of children with cancer.
If you are a parent or legal guardian of a child who was diagnosed with
cancer under the age of 18, please consider completing my questionnaire
to study parental interest as well as factors influencing interest in genetic
counseling and testing services in this parent population. This
questionnaire should take about 5-15 minutes to complete.
https://www.surveymonkey.com/r/ypb9j2h
Thank you!
Lauren"
The link took participants to the online questionnaire on SurveyMonkey.com,
which can be seen in subsequent pages.
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Welcome!

Thank you for your interest in participating in my master's research project. Please review the
study details below prior to completing this survey.
PURPOSE AND BACKGROUND:
You are being asked to volunteer for a research study conducted by Lauren Desrosiers, a graduate student in the Department of
Genetic Counseling at the University of South Carolina. The purpose of this study is to assess interest in genetic counseling among
parents of children diagnosed with cancer. You are being asked to participate in this study because your child has a current or previous
diagnosis of cancer.
PROCEDURES:
If you agree to participate in this study, you will be asked to complete a questionnaire about your familiarity with and interest in genetic
counseling, although no prior knowledge of genetic counseling is required. You will also be asked to provide information about your
family, including your child’s medical history pertaining to their diagnosis of cancer.
DURATION:
Participation in the study will take approximately 5-15 minutes.
PAYMENT TO PARTICIPANTS:
You will not be paid for participating in this study.
VOLUNTARY PARTICIPATION:
Participation in this research study is voluntary. You are free not to participate, or to stop participation at any time, for any reason
without negative consequences. You are not required to answer any question you do not wish to answer. In the event that you do
withdraw from this study, the information you have already provided will be kept in a confidential manner.
If you have any questions, please contact Lauren Desrosiers by phone (803-545-5775) or email (lauren.desrosiers@uscmed.sc.edu).

1. Are you above the age of 18?
Yes
No

2. Are you a parent or legal guardian of a child diagnosed with cancer under the age of 18?
Biological parent
Legal guardian
Other (please specify)
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Cancer History

Please answer the following questions regarding your child who has/had cancer.
3. What is the gender of your child?
Male
Female
Non-binary
Prefer not to respond

4. What type of cancer were they diagnosed with?

5. How old was your child when they were diagnosed with cancer?

6. Has your child been diagnosed with more than one cancer?
Yes
No
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Cancer History

Please answer the following questions regarding your child who has/had cancer.
8. Is your child living or deceased?
Living
Deceased

77

78

79

Cancer History

Please answer the following questions regarding your child who has/had cancer.
12. Is there a history of cancer in the family?
Yes
No
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Perspective on Genetic Counseling

Genetic counselors are trained health care workers that help people understand the role of genetic
factors in disease. They use family and personal medical histories to determine a person’s risk of
having a genetic change that would increase their chance of having cancer. These changes can
cause hereditary cancer syndromes, which may explain why a person developed cancer, and can
also give risk information for family members.
15. Have you heard of genetic counseling before beginning this survey?
Yes
No
Unsure

16. Have you or your child had genetic counseling or genetic testing before? (Please select the best
answer)
Yes
No
Unsure
I was offered genetic counseling or testing, but chose not to accept
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Perspective on Genetic Counseling

Genetic counselors are trained health care workers that help people understand the role of genetic
factors in disease. They use family and personal medical histories to determine a person’s risk of
having a genetic change that would increase their chance of having cancer. These changes can
cause hereditary cancer syndromes, which may explain why a person developed cancer, and can
also give risk information for family members.
18. Is genetic testing for hereditary cancer something you would be interested in pursuing for/with your
child?
Yes
No
Unsure

19. Please indicate how each of the following statements would impact your interest in genetic counseling
or testing with 1=strongly disagree and 5=strongly agree. I would be interested in genetic counseling…
Strongly Disagree

Strongly Agree

If my doctor
recommended it
If the information might
affect my child’s
treatment
If it would impact my
family members’/my
own healthcare
If I could use the
information for family
planning
If my child was older
If my child’s treatment
was complete
If the test was free/low
cost
Other (please specify)

20. What is the best age for genetic counseling or testing?
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Demographic Information

Please complete the following questions. This section helps to classify responses among subsets
of the population and will not be used in any attempts to identify you.
26. What is your gender?
Male
Female
Non-binary
Prefer not to respond

27. How old are you?

28. What race do you most identify with? (Mark all that apply)
Caucasian
Hispanic/Latin American
African-American
Asian/Pacific Islander
American Indian or Alaskan Native
Other (please specify)

29. What is the highest level of education you have completed?
Some high school
High school or GED
Some college
Associate degree
Bachelor degree
Graduate degree
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30. Which of the following best describes your current relationship status?
Married
Divorced/Separated
Widowed
In a domestic partnership or civil union
Single, but living with a significant other
Single/Never married

31. What was your total household income last year?
Less than $25,000
$25,001-$50,000
$50,001-$75,000
$75,001-$100,000
More than $100,000
Prefer not to respond

32. What type of health insurance do you have for your child(ren)?
Private insurance plan (Ex. Aetna, Cigna, etc.)
Medicaid/Medicare
No Insurance
Other (please specify)

33. What is your zip-code?
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APPENDIX D – JONGMANS ET AL. GENETICS REFERRAL CRITERIA
The referral criteria used to identify whether participants had personal or family
history characteristics suggestive of a CPS was developed by researchers from
the Netherlands and published in the journal article cited below. The article is
published under a Creative Commons license, which permits reproduction of
Figure 1 from their paper on the subsequent page.

Jongmans, M. C. J., Loeffen, J. L. C. M., Waanders, E., Hoogerbrugge, P. M.,
Ligtenberg, M. J. L., Kuiper, R. P., & Hoogerbrugge, N. (2016). Recognition
of genetic predisposition in pediatric cancer patients: An easy-to-use
selection tool. European Journal of Medical Genetics, 59(3), 116–125.
https://doi.org/10.1016/j.ejmg.2016.01.008
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